Resilience in Dementia Series
Brain resilience is the process of adapting well in the face of significant sources of stress, such as Alzheimer’s disease pathology, other neurodegenerative conditions or biological aging. This thematic series provides a comprehensive overview of what factors contribute to brain resilience and how this affects brain health and cognitive function.
Guest Editor: Rik Ossenkoppele
Aims and scope
Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.
Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.
Alzheimer's Disease International news
ADI 2018 is the longest running and most diverse international conference on dementia. The conference will feature leading experts on a range of topics including the latest in dementia science and care, presentations by people with dementia and their care partners, discussions on prevention, diagnosis, engaging minority groups and a unique focus on how technology and innovation is shaping the future.
Submit your abstract here by 31 January
Alzheimer's blogs from BMC
Advertisement
Affiliated with
-
Alzheimer's Research & Therapy is affiliated with Alzheimer's Disease International (ADI), London, United Kingdom.
2016 Journal Metrics
-
Speed
26 days from submission to first decision
25 days from acceptance to publicationCitation Impact
6.154 - 2-year Impact Factor
5.664 - 5-year Impact Factor
1.309 - Source Normalized Impact per Paper (SNIP)
2.436 - SCImago Journal Rank (SJR)Usage
301,655 downloads
1456.5 Usage FactorSocial Media Impact
119 mentions
Advertisement
